Higher Dose of Rifampicin for Tuberculosis: Practical Issues

Higher Dose of Rifampicin for Tuberculosis: Practical Issues

Saved in:

Bibliographic Details
Main Author:	Ravindran Chetambath
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-04-01
Series:	Journal of Advanced Lung Health
Online Access:	https://journals.lww.com/10.4103/jalh.jalh_4_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis
by: Nakwon Kwak, et al.
Published: (2025-01-01)

Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis
by: Maria Jose Vadakunnel, et al.
Published: (2025-02-01)

Not So Innocent: Thrombocytopenia After One Dose of Rifampicin
by: Tarana NAGIYEVA, et al.
Published: (2017-12-01)

Low rifampicin concentrations in tuberculosis patients with HIV infection
by: Tanuja Narayansamy Gengiah, et al.
Published: (2014-08-01)

Nonsmoking Chronic Obstructive Pulmonary Disease: Evolution of Understanding in India
by: Ramseena Ibrahim, et al.
Published: (2025-04-01)

Vaping and Lung Injury
by: Ravindran Chetambath, et al.
Published: (2025-07-01)

The Role of Risk Factors in the Development of Tuberculosis in Children Exposed to Rifampicin Resistant Tuberculosis
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)

Molecular Analysis of Rifampicin Resistance Conferring Mutations in Mycobacterium tuberculosis
by: Tawgozy et al.
Published: (2020-05-01)

Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach
by: Satish Kumar, et al.
Published: (2014-12-01)

Prevalence Of Rifampicin Resistance in New Cases Of Pulmonary Tuberculosis In Children
by: Sonia Saleem, et al.
Published: (2024-03-01)

Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia
by: Gebremedhin Bizayene Gebrehiwet, et al.
Published: (2019-01-01)

Predictors of lethal outcome in patients with tuberculosis, resistance to rifampicin, and HIV infection
by: S. S. Saenko, et al.
Published: (2020-06-01)

Comparison of Different Methods for Drug Susceptibility Testing of Mycobacterium tuberculosis to Rifampicin
by: T. V. Umpeleva, et al.
Published: (2022-02-01)

Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria
by: Kenneth Okonkwo Ugwu, et al.
Published: (2020-09-01)

Lethal Risk Factors in Patients with Rifampicin Resistant Tuberculosis according to Federal Register of Tuberculosis Cases
by: I. A. Vasilyeva, et al.
Published: (2024-12-01)

Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis.
by: Sreenivas Achuthan Nair, et al.
Published: (2016-01-01)

GENE MUTATION PATTERNS OF RIFAMPICIN IN MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS COMPLEX STRAINS
by: Esra Yıldırım Servi, et al.
Published: (2022-03-01)

Genetic mutations associated with rifampicin and isoniazid resistance in tuberculosis patients in Bhubaneswar, India
by: Dr Sidhartha Giri, et al.
Published: (2025-03-01)

Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis.
by: Matthew Arentz, et al.
Published: (2013-01-01)

Comparison of Truenat Mycobacterium tuberculosis with line probe assay for the diagnosis of rifampicin resistance and mutation pattern of Mycobacterium tuberculosis
by: Pratik Kumar, et al.
Published: (2025-07-01)

Clinicomicrobiological Profile and Diagnostic Utility of Xpert <italic>Mycobacterium Tuberculosis</italic>/Rifampicin in Pediatric Tuberculosis: An Observational Study
by: Anju Bala, et al.
Published: (2025-01-01)

Sputum microbiota profiles of patients with rifampicin-resistant tuberculosis during the intensive-phase treatment
by: Xingshan Cai, et al.
Published: (2025-07-01)

The identification Mycobacterium tuberculosis genes that modulate long term survival in the presence of rifampicin and streptomycin
by: Johana E. Hernández Toloza, et al.
Published: (2025-07-01)

Assessment of Rifampicin Resistance in Presumptive Tuberculosis Cases at Dadeldhura Hospital of Sudurpaschim Province of Nepal
by: Madan Singh Bohara
Published: (2025-02-01)

Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
by: Bumi Herman, et al.
Published: (2021-01-01)

Healthcare-seeking pathway and delay analysis of rifampicin-resistant tuberculosis patient in Southwestern China
by: Yunbin Yang, et al.
Published: (2025-05-01)

RANGES OF DRUG RESISTANCE OF THE PATHOGEN SENSITIVE TO RIFAMPICIN AND RESISTANT TO ISONIAZID IN PULMONARY TUBERCULOSIS PATIENTS
by: I. A. Burmistrova, et al.
Published: (2019-01-01)

MUTATIONS OF MYCOBACTERIUM TUBERCULOSIS CAUSING RESISTANCE TO RIFAMPICIN AND ISONIAZID IN THE PATIENTS WITH DIFFERENT HIV STATUS
by: E. I. Veselova, et al.
Published: (2019-02-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

RFLP clusters of rifampicin resistant and susceptible Mycobacterium tuberculosis strains in Western province of Sri Lanka
by: Chamila Priyangani Adikaram, et al.
Published: (2017-09-01)

Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Isolates from Moroccan Patients: Systematic Review
by: Rkia Eddabra, et al.
Published: (2020-01-01)

Mental health interventions for rifampicin-resistant tuberculosis patients with alcohol use disorders, Zhytomyr, Ukraine
by: Vitalii Plokhykh, et al.
Published: (2021-09-01)

Association between the rifampicin resistance mutations and rifabutin susceptibility in Mycobacterium tuberculosis: A meta-analysis
by: Wenli Wang, et al.
Published: (2025-01-01)

Study of fluoroquinolones resistance in rifampicin‐resistant tuberculosis patients in Beijing: Characteristics, trends, and treatment outcomes
by: Wang Nenhan, et al.
Published: (2025-05-01)

THE SURGICAL STAGE OF PULMONARY TUBERCULOSIS TREATMENT USING MOLECULAR-GENETIC METHODS TO TEST SUSCEPTIBILITY TO RIFAMPICIN
by: A. V. Golovnin, et al.
Published: (2019-04-01)

Genetic Determinants of Rifampicin Resistance of Mycobacterium tuberculosis not Included in the Russian Molecular Genetic Test Systems
by: E. A. Mazurina, et al.
Published: (2023-07-01)

Evaluation of the Gene Xpert Mycobacterium tuberculosis/resistance to rifampicin assay in rapid diagnosis of tuberculosis and identification of rifampin resistance in tuberculous patients
by: Amal H.G. Hamed, et al.
Published: (2025-01-01)

IMPACT OF EXPRESS SUSCEPTIBILITY TESTING TO RIFAMPICIN OF M. TUBERCULOSIS ON CHEMOTHERAPY EFFICIENCY IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: A. G. Samoylova, et al.
Published: (2016-09-01)

Rifampicin-Associated Secondary Minimal Change Disease Presenting with Nephrotic Syndrome in a Pulmonary Tuberculosis Patient
by: Satyanand Sathi, et al.
Published: (2021-01-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)